CELL INTELLIGENCE · 肿瘤细胞治疗研究

基于 mRNA 的实体瘤癌症疫苗的临床转化

Clinical translation of mRNA-based cancer vaccines for solid tumors.

重新思考晚期肾细胞癌：整合基因组学、免疫治疗与分子-正分子策略

Rethinking Advanced Renal Cell Carcinoma: Integrative Genomics, Immunotherapy, and Molecular-Orthomolecular Strategies.

肾细胞癌肿瘤抗原的发现及临床应用前景

Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application.

SLAMF1 在免疫与疾病交叉路口：生物学、病理学与治疗机会

SLAMF1 at the crossroads of immunity and disease: Biology, pathology, and therapeutic opportunities.

肾细胞癌中碳酸酐酶 IX 与环氧合酶-2 的调控及其对抗 CAIX CAR-T 细胞治疗效率的影响

Carbonic Anhydrase IX and Cyclooxygenase-2 Regulation in Renal Cell Carcinoma and Impact on Therapeutic Efficiency of Anti-CAIX CAR T cells.

这些发现提示 CAIX 与 COX-2 水平之间存在调控相互作用，表明 COX-2 抑制剂可能降低 CAIX 靶向治疗的疗效，在联合治疗中应避免使用。

高 ABCC2 的乳头状肾细胞癌显示出免疫逃逸特征，与免疫治疗的良好反应相关

Papillary renal cell carcinoma with high-ABCC2 shows an immune-evasive profile associated with favorable response to immunotherapy.

碳酸酐酶 IX 免疫疗法下调 PD-L1 促使肾细胞癌采用免疫检查点阻断

PD-L1 downregulation by carbonic anhydrase IX immunotherapy prompts immune checkpoint blockade in renal cell carcinoma.

肾细胞癌的 CAR-T 细胞治疗：机遇、挑战与新的克服策略

CAR T-cell therapy in renal cell carcinoma: opportunities, challenges, and new strategies to overcome.

白细胞介素-2 受体（IL-2R）激动剂在肿瘤免疫治疗中的现状与未来前景

Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy.

用于过继细胞治疗的肾细胞癌肿瘤来源体外扩增 TIL（肿瘤浸润淋巴细胞）的制备与表征

Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.